Acupuncture and Herbal Medicine

Acupuncture and Herbal Medicine is a peer-reviewed English-language journal launched in 2021 by Tianjin University of Traditional Chinese Medicine and the China Association of Chinese Medicine and published on the Wolters Kluwer Lippincott platform, devoted to evidence-based research on acupuncture and herbal medicine, with a 2025 Journal Impact Factor of 7.3《针灸和草药（英文）》是（Tianjin University of Traditional Chinese Medicine）与（China Association of Chinese Medicine）于 2021 年共同创办、在（Wolters Kluwer）（Lippincott）平台出版的英文同行评议期刊，专注针灸与草药的循证研究，2025 年影响因子为 7.3。

Scope

• The journal publishes editorials, review articles, original articles, guidelines and standards, commentaries, short communications, case reports, methodology papers and letters to the editor该刊发表社论、综述、原创论文、指南与标准、评论、短通讯、病例报告、方法学论文以及致编辑的信。
• Evidence-based medicine research in acupuncture and herbal medicine is the defining focus of the journal针灸与草药领域的循证医学研究是该刊的核心定位。
• Clinical trials of acupuncture and studies of its mechanisms of action are welcome针灸临床试验及其作用机制研究均在欢迎之列。
• Herbal medicine and Chinese materia medica research, spanning pharmacology, chemistry and quality standards, fall within scope草药与中药研究，涵盖药理学、化学与质量标准，属于收录范围。
• Guidelines and standards for traditional Chinese medicine, including trial methodology such as core outcome sets, are covered中医药指南与标准，包括核心结局指标集等试验方法学，也在收录范围。
• The journal reports innovative theories and excellent academic achievements in the field of acupuncture and herbal medicine该刊报道针灸与草药领域的创新理论与优秀学术成果。
• Its stated purpose is to promote academic exchange, drive the transformation of research results and serve the international development of traditional Chinese medicine其宗旨是促进学术交流、推动研究成果转化，并服务于中医药的国际化发展。

History

• The journal was launched in 2021, with volume 1, number 1 appearing in September 2021 and a second issue in December 2021该刊 2021 年创刊，第 1 卷第 1 期于 2021 年 9 月上线，第 2 期于 2021 年 12 月出版。
• The founding editorial by Boli Zhang described the journal as a bridge between traditional and modern medicine and announced a diamond open access model with no article processing charge for original research由（Boli Zhang）撰写的创刊辞将该刊定位为传统医学与现代医学之间的桥梁，并宣布采用作者无需缴纳文章处理费的钻石开放获取模式。 ^[1]
• The journal is jointly sponsored by Tianjin University of Traditional Chinese Medicine and the China Association of Chinese Medicine and carries the China serial number CN 12-1467/R该刊由（Tianjin University of Traditional Chinese Medicine）与（China Association of Chinese Medicine）共同主办，国内刊号为 CN 12-1467/R。
• It was selected in 2019 for the high-starting-point new journal programme of the China Science and Technology Journal Excellence Action Plan, which supported its English-language launch该刊 2019 年入选中国科技期刊卓越行动计划高起点新刊项目，为其英文版的创办提供了支持。
• Four issues a year have been published since 2022, and volume 6 covered 2026 with issues in March and June自 2022 年起每年出版 4 期，2026 年为第 6 卷，已出 3 月与 6 月两期。
• Its Journal Impact Factor rose from 4.3 in 2024 to 7.3 in 2025, and the journal is listed in the Emerging Sources Citation Index in the integrative and complementary medicine category其影响因子由 2024 年的 4.3 升至 2025 年的 7.3，并被（Emerging Sources Citation Index）收录于整合与补充医学类别。

Editors

• The editor-in-chief is Boli Zhang, an academician of the Chinese Academy of Engineering at Tianjin University of Traditional Chinese Medicine现任主编为（Boli Zhang），中国工程院院士，任职于（Tianjin University of Traditional Chinese Medicine）。
• The advisory board includes Xuemin Shi and Liang Liu, academicians of the Chinese Academy of Engineering, and Keji Chen and Qi Wang, academicians of the Chinese Academy of Sciences顾问委员会包括中国工程院院士（Xuemin Shi）与（Liang Liu），以及中国科学院院士（Keji Chen）与（Qi Wang）。
• Associate editors are Xiumei Gao, Junhua Zhang, Chunquan Yu, Yan Zhu and Yi Guo of Tianjin University of Traditional Chinese Medicine, Baoyan Liu and Shilin Chen of the China Academy of Chinese Medical Sciences and De-an Guo of the Shanghai Institute of Materia Medica副主编为（Tianjin University of Traditional Chinese Medicine）的（Xiumei Gao）（Junhua Zhang）（Chunquan Yu）（Yan Zhu）与（Yi Guo）、（China Academy of Chinese Medical Sciences）的（Baoyan Liu）与（Shilin Chen），以及（Shanghai Institute of Materia Medica）的（De-an Guo）。
• The international editorial board includes Zhenkun Lou of the Mayo Clinic, Qiufu Ma of Harvard Medical School, Luis Ulloa of Duke University and Changquan Sun of the University of Minnesota in the United States国际编委会包括美国（Mayo Clinic）的（Zhenkun Lou）、（Harvard Medical School）的（Qiufu Ma）、（Duke University）的（Luis Ulloa）与（University of Minnesota）的（Changquan Sun）。
• Board members also come from Japan, South Korea, Kazakhstan, Spain, Italy, Portugal and the Netherlands, among them Toshiaki Makino of Nagoya City University, Myeong Soo Lee of the Korea Institute of Oriental Medicine, Mei Wang of Leiden University and Alice Josephine Fauci of the Istituto Superiore di Sanita编委还来自日本、韩国、哈萨克斯坦、西班牙、意大利、葡萄牙与荷兰，其中包括（Nagoya City University）的（Toshiaki Makino）、（Korea Institute of Oriental Medicine）的（Myeong Soo Lee）、（Leiden University）的（Mei Wang）与（Istituto Superiore di Sanita）的（Alice Josephine Fauci）。
• The editorial office operates from Tianjin University of Traditional Chinese Medicine in Tianjin, and manuscripts are submitted and peer reviewed through the publisher's online platform编辑部设在天津的（Tianjin University of Traditional Chinese Medicine），稿件经出版方在线平台投稿并接受同行评议。